CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today. Total revenues increased 3% to $65.3 billion, driven by growth across all segments. The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits. Net income grew 54.6% to $2.9 billion, […]
“CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today. Total revenues increased 3% to $65.3 billion, driven by growth across all segments. The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits. Net income grew 54.6% to $2.9 billion, […]
· August 5, 2020
CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today.
Total revenues increased 3% to $65.3 billion, driven by growth across all segments.
The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits.
Net income grew 54.6% to $2.9 billion, or $2.26 per share. Adjusted EPS totaled $2.64.
CVS raised its GAAP EPS guidance range to $5.59-5.72 from $5.47-5.60 and adjusted EPS guidance range to $7.14-7.27 from $7.04-7.17.
